Skip to main content

Table 1 Laboratory findings of cholesterol levels

From: Intravascular ultrasound imaging of isolated and non aorto-ostial coronary Takayasu arteritis: a case report

 

LDL-cholesterol (mg/dl)

HDL-cholesterol (mg/dl)

Before treatment

202

76

+ rosuvastatin

90

74

+ ezetimibe

66

76

+ evolocumab

11

64

  1. LDL Low-density lipoprotein; HDL High-density lipoprotein
  2. Legend: Low-density lipoprotein cholesterol level decreased from 202 mg/dl at baseline to 66 mg/dl after administration of rosuvastatin and ezetimibe. The intensive lipid lowering therapy with evolocumab, proprotein convertase subtilicin-kexin type 9 inhibitor, decreased further to 11 mg/dl
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us